Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model

Mazhar Ali Raja,1,2 Martin Maldonado,2 Jianying Chen,2 Ying Zhong,2 Jiang Gu1,2 1Laboratory of Molecular Pathology, Provincial Key Laboratory of Infectious Diseases and Molecular Pathology, Center of Molecular Diagnosis and Personalized Medicine, Shantou University Medical College, Shantou, People’s...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Raja MA, Maldonado M, Chen J, Zhong Y, Gu J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	polycystic ovary syndrome curcumin self- assembled nanoparticles cytotoxicity cellular uptake Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/7a7747ebd50548deb441b02b7bcb66b3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7a7747ebd50548deb441b02b7bcb66b3
record_format	dspace
spelling	oai:doaj.org-article:7a7747ebd50548deb441b02b7bcb66b32021-12-02T18:51:47ZDevelopment and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model1178-2013https://doaj.org/article/7a7747ebd50548deb441b02b7bcb66b32021-09-01T00:00:00Zhttps://www.dovepress.com/development-and-evaluation-of-curcumin-encapsulated-self-assembled-nan-peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Mazhar Ali Raja,1,2 Martin Maldonado,2 Jianying Chen,2 Ying Zhong,2 Jiang Gu1,2 1Laboratory of Molecular Pathology, Provincial Key Laboratory of Infectious Diseases and Molecular Pathology, Center of Molecular Diagnosis and Personalized Medicine, Shantou University Medical College, Shantou, People’s Republic of China; 2Chengdu Jinxin Research Institute for Reproductive Medicine and Genetics, Reproductive Center of Chengdu Jinjiang District Maternal and Child Health Hospital, Chengdu, People’s Republic of ChinaCorrespondence: Jiang GuLaboratory of Molecular Pathology, Provincial Key Laboratory of Infectious Diseases and Molecular Pathology, Center of Molecular Diagnosis and Personalized Medicine, Shantou University Medical College, Xinling Road 22, Shantou, Guangdong, 515041, People’s Republic of ChinaEmail 2523381625@qq.com; jgu@stu.edu.cnYing ZhongChengdu Jinxin Research Institute for ReproductiveMedicine and Genetics, ReproductiveCenter of Chengdu Jinjiang District Maternal and Child Health Hospital, No. 66, 88 Bi Sheng Road, Chengdu, 610023, People’s Republic of ChinaEmail zhongy@jxr-fertility.comPurpose: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting women of reproductive age and leads to metabolic disorders and infertility. The present study was conducted to investigate the therapeutic effects of curcumin (Cur) encapsulated arginine (Arg) and N-acetyl histidine (NAcHis) modified chitosan (Arg-CS-NAcHis/Cur) nanoparticles (NPs).Methods: In this study, amphiphilic chitosan (CS) conjugate was developed by modification with hydrophilic arginine (Arg) and hydrophobic N-acetyl histidine (NAcHis) group (Arg-CS-NAcHis). The synthesized conjugate was well characterized by FTIR and NMR studies. Self-assembled nanoparticles based on the synthesized conjugate were developed by simple sonication method and characterized for the physicochemical properties of zeta potential, particle size and drug encapsulation. Next, in vitro drug release, cytotoxicity, and cellular uptake studies of the NPs were evaluated. Finally, the developed nanoparticles were examined for their therapeutic potential against estradiol valerate (EV) induced PCOS rats by evaluating hormone level changes and ovarian morphology.Results: The results showed that zeta potential of the nanoparticles was 39.8± 2.52 mV and the average size was 200 nm. The in vitro drug release profile showed sustained release pattern. Cytotoxicity and cellular uptake studies also showed preferential effectiveness than free curcumin. Both the biochemical and histopathological studies showed positive effects in reverting the symptoms of PCOS rats to normalcy.Conclusion: Curcumin encapsulated arginine and N-acetyl histidine modified chitosan (Arg-CS-NAcHis/Cur) nanoparticles have been successfully developed. The present study suggested that treatment of the nanoparticles might reverse many of the PCOS symptoms. Therefore, these nanoparticles might be used as promising new candidate for delivery of curcumin to treat PCOS.Keywords: polycystic ovary syndrome, curcumin, self-assembled nanoparticles, cytotoxicity, cellular uptakeRaja MAMaldonado MChen JZhong YGu JDove Medical Pressarticlepolycystic ovary syndromecurcuminself- assembled nanoparticlescytotoxicitycellular uptakeMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 6231-6247 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	polycystic ovary syndrome curcumin self- assembled nanoparticles cytotoxicity cellular uptake Medicine (General) R5-920
spellingShingle	polycystic ovary syndrome curcumin self- assembled nanoparticles cytotoxicity cellular uptake Medicine (General) R5-920 Raja MA Maldonado M Chen J Zhong Y Gu J Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
description	Mazhar Ali Raja,1,2 Martin Maldonado,2 Jianying Chen,2 Ying Zhong,2 Jiang Gu1,2 1Laboratory of Molecular Pathology, Provincial Key Laboratory of Infectious Diseases and Molecular Pathology, Center of Molecular Diagnosis and Personalized Medicine, Shantou University Medical College, Shantou, People’s Republic of China; 2Chengdu Jinxin Research Institute for Reproductive Medicine and Genetics, Reproductive Center of Chengdu Jinjiang District Maternal and Child Health Hospital, Chengdu, People’s Republic of ChinaCorrespondence: Jiang GuLaboratory of Molecular Pathology, Provincial Key Laboratory of Infectious Diseases and Molecular Pathology, Center of Molecular Diagnosis and Personalized Medicine, Shantou University Medical College, Xinling Road 22, Shantou, Guangdong, 515041, People’s Republic of ChinaEmail 2523381625@qq.com; jgu@stu.edu.cnYing ZhongChengdu Jinxin Research Institute for ReproductiveMedicine and Genetics, ReproductiveCenter of Chengdu Jinjiang District Maternal and Child Health Hospital, No. 66, 88 Bi Sheng Road, Chengdu, 610023, People’s Republic of ChinaEmail zhongy@jxr-fertility.comPurpose: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting women of reproductive age and leads to metabolic disorders and infertility. The present study was conducted to investigate the therapeutic effects of curcumin (Cur) encapsulated arginine (Arg) and N-acetyl histidine (NAcHis) modified chitosan (Arg-CS-NAcHis/Cur) nanoparticles (NPs).Methods: In this study, amphiphilic chitosan (CS) conjugate was developed by modification with hydrophilic arginine (Arg) and hydrophobic N-acetyl histidine (NAcHis) group (Arg-CS-NAcHis). The synthesized conjugate was well characterized by FTIR and NMR studies. Self-assembled nanoparticles based on the synthesized conjugate were developed by simple sonication method and characterized for the physicochemical properties of zeta potential, particle size and drug encapsulation. Next, in vitro drug release, cytotoxicity, and cellular uptake studies of the NPs were evaluated. Finally, the developed nanoparticles were examined for their therapeutic potential against estradiol valerate (EV) induced PCOS rats by evaluating hormone level changes and ovarian morphology.Results: The results showed that zeta potential of the nanoparticles was 39.8± 2.52 mV and the average size was 200 nm. The in vitro drug release profile showed sustained release pattern. Cytotoxicity and cellular uptake studies also showed preferential effectiveness than free curcumin. Both the biochemical and histopathological studies showed positive effects in reverting the symptoms of PCOS rats to normalcy.Conclusion: Curcumin encapsulated arginine and N-acetyl histidine modified chitosan (Arg-CS-NAcHis/Cur) nanoparticles have been successfully developed. The present study suggested that treatment of the nanoparticles might reverse many of the PCOS symptoms. Therefore, these nanoparticles might be used as promising new candidate for delivery of curcumin to treat PCOS.Keywords: polycystic ovary syndrome, curcumin, self-assembled nanoparticles, cytotoxicity, cellular uptake
format	article
author	Raja MA Maldonado M Chen J Zhong Y Gu J
author_facet	Raja MA Maldonado M Chen J Zhong Y Gu J
author_sort	Raja MA
title	Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title_short	Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title_full	Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title_fullStr	Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title_full_unstemmed	Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
title_sort	development and evaluation of curcumin encapsulated self-assembled nanoparticles as potential remedial treatment for pcos in a female rat model
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/7a7747ebd50548deb441b02b7bcb66b3
work_keys_str_mv	AT rajama developmentandevaluationofcurcuminencapsulatedselfassemblednanoparticlesaspotentialremedialtreatmentforpcosinafemaleratmodel AT maldonadom developmentandevaluationofcurcuminencapsulatedselfassemblednanoparticlesaspotentialremedialtreatmentforpcosinafemaleratmodel AT chenj developmentandevaluationofcurcuminencapsulatedselfassemblednanoparticlesaspotentialremedialtreatmentforpcosinafemaleratmodel AT zhongy developmentandevaluationofcurcuminencapsulatedselfassemblednanoparticlesaspotentialremedialtreatmentforpcosinafemaleratmodel AT guj developmentandevaluationofcurcuminencapsulatedselfassemblednanoparticlesaspotentialremedialtreatmentforpcosinafemaleratmodel
_version_	1718377392747053056

Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model

Ejemplares similares